Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response

被引:46
作者
Rui, Yuxiang [1 ]
Honjo, Tasuku [1 ]
Chikuma, Shunsuke [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto 6068501, Japan
关键词
autoimmunity; inflammation; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; DENDRITIC CELLS; PD-1; GENE; REGULATORY POLYMORPHISM; PERTUSSIS TOXIN; EXPRESSION; IL-6; RECEPTOR; SUSCEPTIBILITY; MACROPHAGES;
D O I
10.1073/pnas.1315828110
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Programmed cell death 1 (PD-1) is an inhibitory coreceptor on immune cells and is essential for self-tolerance because mice genetically lacking PD-1 (PD-1(-/-)) develop spontaneous autoimmune diseases. PD-1(-/-) mice are also susceptible to severe experimental autoimmune encephalomyelitis (EAE), characterized by a massive production of effector/memory T cells against myelin autoantigen, the mechanism of which is not fully understood. We found that an increased primary response of PD-1(-/-) mice to heat-killed mycobacteria (HKMTB), an adjuvant for EAE, contributed to the enhanced production of T-helper 17 (Th17) cells. Splenocytes from HKMTB-immunized, lymphocyte-deficient PD-1(-/-) recombination activating gene (RAG)2(-/-) mice were found to drive antigen-specific Th17 cell differentiation more efficiently than splenocytes from HKMTB-immunized PD-1(+/+) RAG2(-/-) mice. This result suggested PD-1's involvement in the regulation of innate immune responses. Mice reconstituted with PD-1(-/-) RAG2(-/-) bone marrow and PD-1(+/+) CD4(+) T cells developed more severe EAE compared with the ones reconstituted with PD-1(+/+) RAG2(-/-) bone marrow and PD-1(+/+) CD4(+) T cells. We found that upon recognition of HKMTB, CD11b(+) macrophages from PD-1(-/-) mice produced very high levels of IL-6, which helped promote naive CD4(+) T-cell differentiation into IL-17-producing cells. We propose a model in which PD-1 negatively regulates antimycobacterial responses by suppressing innate immune cells, which in turn prevents autoreactive T-cell priming and differentiation to inflammatory effector T cells.
引用
收藏
页码:16073 / 16078
页数:6
相关论文
共 45 条
  • [21] PD-L2 is a second ligand for PD-I and inhibits T cell activation
    Latchman, Y
    Wood, CR
    Chernova, T
    Chaudhary, D
    Borde, M
    Chernova, I
    Iwai, Y
    Long, AJ
    Brown, JA
    Nunes, R
    Greenfield, EA
    Bourque, K
    Boussiotis, VA
    Carter, LL
    Carreno, BM
    Malenkovich, N
    Nishimura, H
    Okazaki, T
    Honjo, T
    Sharpe, AH
    Freeman, GJ
    [J]. NATURE IMMUNOLOGY, 2001, 2 (03) : 261 - 268
  • [22] Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis
    Lazar-Molnar, Eszter
    Chen, Bing
    Sweeney, Kari A.
    Wang, Emilie J.
    Liu, Weijun
    Lin, Juan
    Porcelli, Steven A.
    Almo, Steven C.
    Nathenson, Stanley G.
    Jacobs, William R., Jr.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (30) : 13402 - 13407
  • [23] Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses
    Liang, SC
    Latchman, YE
    Buhlmann, JE
    Tomczak, MF
    Horwitz, BH
    Freeman, GJ
    Sharpe, AH
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (10) : 2706 - 2716
  • [24] Role of interleukin-12 family cytokines in the cellular response to mycobacterial disease
    Mendez-Samperio, Patricia
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 (05) : E366 - E371
  • [25] Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes
    Nielsen, C
    Hansen, D
    Husby, S
    Jacobsen, BB
    Lillevang, ST
    [J]. TISSUE ANTIGENS, 2003, 62 (06): : 492 - 497
  • [26] Immunological studies on PD-1-deficient mice: implication of PD-1 as a negative regulator for B cell responses
    Nishimura, H
    Minato, N
    Nakano, T
    Honjo, T
    [J]. INTERNATIONAL IMMUNOLOGY, 1998, 10 (10) : 1563 - 1572
  • [27] Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice
    Nishimura, H
    Okazaki, T
    Tanaka, Y
    Nakatani, K
    Hara, M
    Matsumori, A
    Sasayama, S
    Mizoguchi, A
    Hiai, H
    Minato, N
    Honjo, T
    [J]. SCIENCE, 2001, 291 (5502) : 319 - 322
  • [28] Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor
    Nishimura, H
    Nose, M
    Hiai, H
    Minato, N
    Honjo, T
    [J]. IMMUNITY, 1999, 11 (02) : 141 - 151
  • [29] PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine
    Okazaki, T
    Maeda, A
    Nishimura, H
    Kurosaki, T
    Honjo, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) : 13866 - 13871
  • [30] PD-1 and PD-1 ligands: from discovery to clinical application
    Okazaki, Taku
    Honjo, Tasuku
    [J]. INTERNATIONAL IMMUNOLOGY, 2007, 19 (07) : 813 - 824